San Antonio, TX - SABCS 2012 San Antonio Breast Cancer Symposium: KN Bhalla discusses S3-7. Treatment with histone deacetylase inhibitors creates
’BRCAness’ and sensitizes human triple negative breast cancer
cells to PARP inhibitors and cisplatin during the General Session 3 at the 2012 San Antonio Breast Cancer Symposium here today, Thursday December 6, 2012. Over 9,000 physicians, researchers, patient advocates and healthcare professionals from over 90 countries attended the meeting which features the latest research on breast cancer treatment and prevention. Date: Thursday December 6, 2012 Photo by © SABCS/Todd Buchanan 2012 Technical Questions: email@example.com; Phone: 612-226-5154.